Cover Image

The Effect of Chinese Medicine on Lipid and Glucose Metabolism in Acute Myocardial Infarction Through PPARγ Pathway

Aim: Danqi Pill (DQP), a Chinese medicine frequently prescribed in China, has been approved to improve cardiac function by regulating cardiac energy metabolism in heart failure (HF) after acute myocardial infarction (AMI) patients. The aim of this study was to explore whether the mechanism of DQP is...

Full description

Saved in:

Bibliographic Details
Main Authors:	Qian Zhang (Author), Mingyan Shao (Author), Xuefeng Zhang (Author), Qiyan Wang (Author), Dongqing Guo (Author), Xiaomin Yang (Author), Chun Li (Author), Yong Wang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2018-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Danqi Pill Protects Against Heart Failure Post-Acute Myocardial Infarction via HIF-1α/PGC-1α Mediated Glucose Metabolism Pathway
by: Qian Zhang, et al.
Published: (2020)

Gegen Qinlian Decoction Coordinately Regulates PPARγ and PPARα to Improve Glucose and Lipid Homeostasis in Diabetic Rats and Insulin Resistance 3T3-L1 Adipocytes
by: Jun Tu, et al.
Published: (2020)

Ups and downs: The PPARγ/p-PPARγ seesaw of follistatin-like 1 and integrin receptor signaling in adipogenesis
by: Dongliang Fang, et al.
Published: (2022)

Neobavaisoflavone Induces Bilirubin Metabolizing Enzyme UGT1A1 via PPARα and PPARγ
by: Ya-Di Zhu, et al.
Published: (2021)

PPARγ overexpression regulates cholesterol metabolism in human L02 hepatocytes
by: Tao Han, et al.
Published: (2019)

Genistein Modulated Lipid Metabolism, Hepatic PPARγ, and Adiponectin Expression in Bilateral Ovariectomized Rats with Nonalcoholic Steatohepatitis (NASH)
by: Sudaporn Pummoung, et al.
Published: (2020)

Selective Tissue Distribution Mediates Tissue-Dependent PPARγ Activation and Insulin Sensitization by INT131, a Selective PPARγ Modulator
by: Xinni Xie, et al.
Published: (2017)

PPARγ in Ischemia-Reperfusion Injury: Overview of the Biology and Therapy
by: Ruizhen Huang, et al.
Published: (2021)

Features of the in-hospital course of myocardial infarction in patients with glucose metabolism disorders
by: B. U. Mardanov, et al.
Published: (2015)

Features of the in-hospital course of myocardial infarction in patients with glucose metabolism disorders
by: B. U. Mardanov, et al.
Published: (2015)

PECULIARITIES OF PURINE METABOLISM AND LIPID PEROXIDATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
by: E. V. Horolets, et al.
Published: (2016)

CARBOHYDRATE AND LIPID IN MYOCARDIAL INFARCTION
by: K.Montazemi, et al.
Published: (1984)

CARBOHYDRATE AND LIPID IN MYOCARDIAL INFARCTION
by: K.Montazemi, et al.
Published: (1984)

The TFPI2-PPARγ axis induces M2 polarization and inhibits fibroblast activation to promote recovery from post-myocardial infarction in diabetic mice
by: Mengqi Guo, et al.
Published: (2023)

Protective Effect of Combined Metoprolol and Atractylenolide I in Rats with Acute Myocardial Infarction via Modulation of the SIRT3/β-CATENIN/PPAR-γ Signaling Pathway
by: Weijian Zhou, et al.
Published: (2023)

Long Noncoding RNA lnc-HC Regulates PPARγ-Mediated Hepatic Lipid Metabolism through miR-130b-3p
by: Xi Lan, et al.
Published: (2019)

Pro-angiogenic Role of Danqi Pill Through Activating Fatty Acids Oxidation Pathway Against Coronary Artery Disease
by: Shihong Jiao, et al.
Published: (2018)

Mechanistic Insight into PPARγ and Tregs in Atherosclerotic Immune Inflammation
by: Zhao Gao, et al.
Published: (2021)

Biotin and chromium histidinate improve glucose metabolism and proteins expression levels of IRS-1, PPAR-γ, and NF-κB in exercise-trained rats
by: Mine Turgut, et al.
Published: (2018)

Breviscapine remodels myocardial glucose and lipid metabolism by regulating serotonin to alleviate doxorubicin-induced cardiotoxicity
by: Meng-Jiao Li, et al.
Published: (2022)

PPARγ Agonists: Emergent Therapy in Endometriosis
by: Alexandre Vallée, et al.
Published: (2021)

Identification of an irreversible PPARγ antagonist with potent anticancer activity
by: Youyi Peng, et al.
Published: (2020)

Fruits of Rosa laevigata and its bio-active principal sitostenone facilitate glucose uptake and insulin sensitivity in hepatic cells via AMPK/PPAR-γ activation
by: K.J. Senthil Kumar, et al.
Published: (2021)

PPARγ and PPARα synergize to induce robust browning of white fat in vivo
by: Tobias Kroon, et al.
Published: (2020)

The Prognostic Value of the Triglyceride Glucose Index in Patients With Acute Myocardial Infarction
by: Qian Hao PhD, et al.
Published: (2023)

Betulinic acid lowers lipid accumulation in adipocytes through enhanced NCoA1-PPARγ interaction
by: Al-Mutary Mohsen G, et al.
Published: (2019)

Bronchopulmonary Dysplasia: Crosstalk Between PPARγ, WNT/β-Catenin and TGF-β Pathways; The Potential Therapeutic Role of PPARγ Agonists
by: Yves Lecarpentier, et al.
Published: (2019)

A glimpse of the connection between PPARγ and macrophage
by: Lexiang Yu, et al.
Published: (2023)

Preclinical Investigation of Alpinetin in the Treatment of Cancer-Induced Cachexia via Activating PPARγ
by: Yujie Zhang, et al.
Published: (2021)

Engeletin inhibits Lipopolysaccharide/d-galactosamine-induced liver injury in mice through activating PPAR-γ
by: Qing Tian, et al.
Published: (2019)

Fenofibrate suppresses corneal neovascularization by regulating lipid metabolism through PPARα signaling pathway
by: Tong Zhou, et al.
Published: (2022)

D-arabinose acts as antidepressant by activating the ACSS2-PPARγ/TFEB axis and CRTC1 transcription
by: Yaxin Guo, et al.
Published: (2024)

No-reflow phenomenon and triglyceride-glucose index in acute myocardial infarction
by: Murat Kerkutluoglu, et al.
Published: (2023)

Repurposing of substances with lactone moiety for the treatment of γ-Hydroxybutyric acid and γ-Butyrolactone intoxication through modulating paraoxonase and PPARγ
by: Sepand Tehrani Fateh, et al.
Published: (2022)

Deciphering the active constituents of Dabushen decoction of ameliorating osteoarthritis via PPARγ preservation by targeting DNMT1
by: Lu Qiu, et al.
Published: (2022)

Nephropathy 1st inhibits renal fibrosis by activating the PPARγ signaling pathway
by: Linjie Mu, et al.
Published: (2022)

Roles of protein post-translational modifications in glucose and lipid metabolism: mechanisms and perspectives
by: Yu-Hang Yang, et al.
Published: (2023)

Therapeutic Opportunities for Intestinal Angioectasia‐ Targeting PPARγ and Oxidative Stress
by: Mayur Sarangdhar, et al.
Published: (2021)

Stereospermum tetragonam as an antidiabetic agent by activating PPARγ and GLUT4
by: Bino Kingsley, et al.
Published: (2014)

PPARγ is dispensable for clear cell renal cell carcinoma progression
by: Danielle J. Sanchez, et al.
Published: (2018)